PDCD1 and neoplasm: Treatment with anti‐PD‐1 antibody alone only slightly inhibited tumor growth of B16F10 melanoma cells, while a relatively low dose of Mito‐ATO (2 × 10−3m) alone inhibited but did not eradicate tumor growth.